Pardridge, William; Boado, Ruben
doi: 10.1007/s11095-009-9939-6pmid: 19609743
A no-observable-adverse-effect level is established in the Rhesus monkey for the acute administration of the HIRMAb-GDNF fusion protein. The fusion protein targeting the insulin receptor has a PK profile similar to a classical small molecule.